Back

Safety and efficacy of non-vitamin K antagonist oral anticoagulants compared to warfarin in patients with atrial fibrillation and end stage renal disease: a meta-analysis of randomized trials

28 August 2023 (13:15 - 14:00)
Organised by: Logo
Congress Presentation Part of: Atrial fibrillation stroke prevention with oral anticoagulants in difficult cases Oral Anticoagulation ESC Professional Premium Access ESC Congress 2023 European Society of Cardiology

About the speaker

Photo
Doctor Tze-Fan Chao

Taipei Veterans General Hospital, Taipei (Taiwan)

7 More presentations in this session

Presentation thumbnail
Anticoagulation-associated bleeding in patients randomised to screening for atrial fibrillation or usual care
Doctor E. Kongebro (Copenhagen, DK)
Abstract Slides Video
Presentation thumbnail
Safety and efficacy of anticoagulation for atrial fibrillation in cirrhotic patients
Doctor J. Song (Los Angeles, US)
Abstract Slides Video
Presentation thumbnail
Long-term effectiveness and safety of edoxaban in patients with atrial fibrillation: 4-year follow-up of more than 13,000 patients from the ETNA-AF-Europe study
Professor R. De Caterina (Pisa, IT)
Abstract Slides Video
Presentation thumbnail
Anticoagulation therapy in patients with atrial fibrillation and active cancer
Doctor J. Jaakkola (Turku, FI)
Abstract Slides Video
Presentation thumbnail
Individual risk prediction of anticoagulation in atrial fibrillation patients with cirrhosis
Assistant Professor I. Kim (Seoul, KR)
Abstract Slides Video

Access the full session

Session thumbnail
Atrial fibrillation stroke prevention with oral anticoagulants in difficult cases

The Event

Event poster

ESC Congress 2023

28 August 2023 13:15 CET
You may be interested in
thumbnail
Congress Presentation
Comparing the efficacy and safety of DOACs with VKAs in patients with end-stage kidney disease on dialysis and non-valvular atrial fibrillation: a systematic review and meta-analysis
thumbnail
Congress Presentation
Use of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation across five stages of chronic kidney diseases
thumbnail
Congress Presentation
Comparative analysis of oral anticoagulation therapy in Asian patients with atrial fibrillation and end-stage renal disease: a nationwide population-based cohort study

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources